$CYTK CYTOKINETICS INC Insiders
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CYTOKINETICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of current and past insiders in CYTOKINETICS INC. Find out how many shares they currently own, their value and whether they buy or sell their shares.
CYTOKINETICS INC Insiders
Name | Position | Total Shares | Current Value ($) | Last 3 Months | Buy / Sell | Last Transaction | |
---|---|---|---|---|---|---|---|
BARBARI SHARON SURREY | EVP, Finance & CFO | 47,640 | 557,388 | Mar 02 2017 | |||
BARBARI SHARON SURREY | EVP, Finance & CFO | 24,778 | 289,903 | Feb 26 2014 | |||
Bhanji Muna | Director | 5,000 | 58,500 | May 13 2021 | |||
Blum Robert I | President & CEO | 361,859 | 4,233,750 | May 07 2021 | |||
Blum Robert I | President & CEO | 3,276 | 38,329 | Feb 26 2014 | |||
BVF PARTNERS L P/IL | 10% Owner | 3,811,271 | 44,591,871 | Dec 11 2020 | |||
Califf Robert | Director | 5,459 | 63,870 | May 13 2021 | |||
Callos Andrew | EVP, Chief Commercial Officers | 0 | 0 | Apr 05 2021 | |||
CHARPENTIER BONNIE | SVP Regulatory & Compliance | 15,000 | 175,500 | Mar 02 2017 | |||
CHARPENTIER BONNIE | SVP Regulatory & Compliance | 0 | 0 | Feb 03 2014 | |||
COSTA SANTO J | Director | 5,000 | 58,500 | May 13 2021 | |||
COSTA SANTO J | Director | 0 | 0 | May 22 2014 | |||
Cragg David | SVP Human Resources | 160,625 | 1,879,313 | Mar 09 2021 | |||
CREDIT SUISSE FIRST BOSTON/ | 10% Owner | 1,765,683 | 20,658,491 | May 05 2004 | |||
DOW STEPHEN M | Director | 60,000 | 702,000 | Oct 29 2004 | |||
DOW STEPHEN M | Director | 3,164,003 | 37,018,835 | Apr 29 2004 | |||
DOW STEPHEN M | Director | 1,421,052 | 16,626,308 | Jan 04 2013 | |||
Eastern Capital LTD | 10% Owner | 2,883,845 | 33,740,987 | Feb 27 2014 | |||
GAGE L PATRICK | Director | 27,529 | 322,089 | May 13 2021 | |||
GAGE L PATRICK | Director | 850 | 9,945 | May 22 2014 | |||
GILBERT DENISE | Director | 0 | 0 | May 21 2015 | |||
GILBERT DENISE | Director | 0 | 0 | May 22 2014 | |||
HEIDRICH A GRANT III | Director | 93,755 | 1,096,934 | Jan 05 2011 | |||
HENDERSON JOHN T | Director | 12,410 | 145,197 | May 13 2021 | |||
HENDERSON JOHN T | Director | 0 | 0 | Jan 05 2015 | |||
HOMCY CHARLES J | Director | 0 | 0 | May 27 2008 | |||
JAGGERS JOHN V | 10% Owner | 3,164,003 | 37,018,835 | Apr 29 2004 | |||
Jaw Ching | SVP Finance & CFO | 88,492 | 1,035,356 | Mar 09 2021 | |||
Kaye Edward M. MD | Director | 5,920 | 69,264 | May 13 2021 | |||
Malik Fady Ibraham | EVP Research & Development | 160,348 | 1,876,072 | May 13 2021 | |||
MAYFIELD IX | 10% Owner | 13,705 | 160,349 | May 04 2004 | |||
MCDADE MARK | Director | 0 | 0 | May 22 2009 | |||
McDowell Caryn Gordon | GC & Chief Compliance Officer | 35,000 | 409,500 | Mar 01 2018 | |||
Morgan Bradley Paul | SVP Drug Discovery & Early Dev | 63,107 | 738,352 | Sep 01 2017 | |||
MORGANS DAVID J JR | EVP-Preclinical R&D | 42,000 | 491,400 | Mar 01 2011 | |||
PARSHALL B LYNNE | Director | 5,000 | 58,500 | May 13 2021 | |||
PARSHALL B LYNNE | Director | 0 | 0 | Jan 05 2015 | |||
RABSON MICHAEL | SVP Business Dev/Legal & GC | 20,043 | 234,503 | Dec 21 2009 | |||
RODDY PETER S | SVP Finance & CAO | 21,520 | 251,784 | Mar 01 2018 | |||
RUTTER WILLIAM J | Director | 172,413 | 2,017,232 | May 03 2004 | |||
Sabry James H | Director | 0 | 0 | Jun 04 2010 | |||
SCHLOSSBERG MARK A | SVP - Legal & General Counsel | 50,850 | 594,945 | Mar 09 2021 | |||
SCHMERTZLER MICHAEL | Director | 3,105,261 | 36,331,554 | May 23 2005 | |||
SCHMERTZLER MICHAEL | Director | 0 | 0 | Jan 06 2009 | |||
SCHMERTZLER MICHAEL | Director | 5,389,208 | 63,053,734 | May 22 2009 | |||
SCHMERTZLER MICHAEL | Director | 4,340,923 | 50,788,799 | Jun 04 2010 | |||
Schnieders Elisabeth | Sr. VP, Business Development | 28,985 | 339,125 | Mar 02 2017 | |||
SEVIN ROSEN FUND VI LP | 10% Owner | 1,615,716 | 18,903,877 | Apr 29 2004 | |||
SEVIN ROSEN FUND VII LP | 10% Owner | 625,950 | 7,323,615 | Apr 29 2004 | |||
SEVIN ROSEN FUND VIII LP | 10% Owner | 755,631 | 8,840,883 | Apr 29 2004 | |||
SEVIN ROSEN VI AFFILIATES FUND LP | 10% Owner | 127,235 | 1,488,650 | Apr 29 2004 | |||
SEVIN ROSEN VII AFFILIATES FUND LP | 10% Owner | 24,050 | 281,385 | Apr 29 2004 | |||
SEVIN ROSEN VIII AFFILIATES FUND LP | 10% Owner | 15,421 | 180,426 | Apr 29 2004 | |||
SMITH SANDFORD D | Director | 5,920 | 69,264 | May 13 2021 | |||
SMITH SANDFORD D | Director | 0 | 0 | Jan 05 2015 | |||
SPUDICH JAMES A | Director | 180,600 | 2,113,020 | May 19 2011 | |||
SRB ASSOCIATES VI LP | 10% Owner | 1,742,951 | 20,392,527 | Apr 29 2004 | |||
SRB ASSOCIATES VII LP | 10% Owner | 650,000 | 7,605,000 | Apr 29 2004 | |||
SRB ASSOCIATES VIII LP | 10% Owner | 771,052 | 9,021,308 | Apr 29 2004 | |||
TRAUTMAN JAY K | VP, Discovery Research | 47,896 | 560,383 | Mar 04 2008 | |||
WIERENGA WENDALL | Director | 0 | 0 | Jan 05 2015 | |||
WIERENGA WENDALL D | Director | 5,920 | 69,264 | May 13 2021 | |||
WOLFF ANDREW A | SVP & CMO | 37,239 | 435,696 | Mar 02 2017 | |||
WOLFF ANDREW A | SVP Clinical R&D, CMO | 20,637 | 241,453 | Sep 05 2013 | |||
Wong Robert | VP, Chief Accounting Officer | 23,879 | 279,384 | Mar 09 2021 | |||
Wysenski Nancy | Director | 5,459 | 63,870 | May 13 2021 |